Back
Travere Therapeutics 10K Form
Sell
37
TVTX
Travere Therapeutics
Last Price:
18.5700
Seasonality Move:
13.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TVTX News And Ratings
See the #1 stock for the next 7 days that we like better than TVTX
TVTX Financial Statistics
Sales & Book Value
Annual Sales: | $145.24M |
---|---|
Cash Flow: | $-50.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.39 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -4.55000 |
---|---|
Net Income (TTM): | $-351.45M |
Gross Margin: | $133.79M |
Return on Equity: | -325.82% |
Return on Assets: | -52.6% |
Travere Therapeutics Earnings Forecast
Key Travere Therapeutics Financial Ratios
- The Gross Profit Margin over the past 11 years for TVTX is 92.12%.
- The Selling, General & Administrative Expenses for TVTX have been equal to 182.83% of Gross Profit Margin.
- The Research & Development expenses have been 168.68% of Revenue.
- The Interest Expense is -10.17% of Operating Income.
- The Net Earning history of TVTX is -76.70% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 4 years.
Travere Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | TVTX |
CUSIP: | 89422G |
Website: | travere.com |
Debt
Debt-to-Equity Ratio: | -12.43 |
---|---|
Current Ratio: | 1.71 |
Quick Ratio: | 1.59 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
TVTX Technical Analysis vs Fundamental Analysis
Sell
37
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics a Buy or a Sell?
-
Travere Therapeutics stock is rated a Sell
The current Travere Therapeutics [TVTX] share price is $18.7500. The Score for TVTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.